Patients differ. The more precise the diagnosis and the more targeted the therapy, the better the individual needs of patients can be met. This is the goal of The LOOP Zurich. The new translational research center wants to improve our basic understanding of diseases to develop therapies that are tailored to the individual. To this end, it combines basic research in biomedicine and bioinformatics from the University of Zurich (UZH) and ETH Zurich with clinical research from Zurich’s university hospitals – the University Hospital Zurich (USZ), the University Children’s Hospital Zurich (KiSpi), the University Hospital Balgrist and the University Hospital of Psychiatry Zurich (PUK).
The hospitals’ unparalleled access to patients and the combined research infrastructures at UZH and ETH provide The Loop Zurich with a unique starting point. “We’re bringing together the best researchers in biomedical research, clinical research and bioinformatics to conduct innovative research together,” says Beatrice Beck-Schimmer, Vice President Medicine at UZH. Detlef Günther, Vice President for Research at ETH Zurich and Chair of the Executive Board of the University Medicine Zurich initiative, adds: “We have the basic research, innovative diagnostics and specialist knowledge in handling medical data to frame and answer excellent scientific questions together. If we can tap into the interdisciplinary potential of The LOOP Zurich, we will also succeed in bringing the benefits of innovation to patients in the clinics as quickly as possible.” The cooperation is expected to bolster precision medicine at the Zurich research hub.
Built on biomedical informatics
One of the new center’s core competencies is in biomedical informatics. To develop bespoke therapies for patients, the research center wants to use improved data analysis and data modeling to gain new insights in diagnostics, therapy and prevention.
The involved institutions have large data collections, but they don’t yet share the research infrastructure needed to exchange and benefit from this medical data in a suitable way. This is set to change with the center’s new biomedical informatics platform, which will be based on the standards of the Swiss Personalized Health Network, the Swiss government’s initiative to make health data interoperable and accessible for research. The new platform will make previously unused data available for use in clinical decision support systems.
First focal points defined
The center recently launched the first two research consortia, each funded to the tune of CHF 5 million over the next five years (see below). The researchers involved will work hand in hand to develop novel precision therapies in the fields of oncology and neurorehabilitation. “The projects were chosen for their scientific excellence, and because Zurich has proven specialist knowledge in these areas. This allows us to take on an important role internationally,” explains Markus Rudin, Founding Director of The LOOP Zurich.
The research consortium StimuLOOP led by Professor Andreas Luft (UZH) and Professor Roger Gassert (ETH Zurich) explores motor rehabilitation in stroke and Parkinson’s patients. “We want to use personalized rehabilitation therapies to improve the patients’ movement in the long term,” says neurologist Andreas Luft.